1. Macrophage-based therapeutic approaches for cardiovascular diseases

   • Marida Sansonetti
   • Bashar Al Soodi
   • Mira Jung

   Review Open access 03 January 2024 Pages: 1 - 33

   

2. Macrophage profiling in atherosclerosis: understanding the unstable plaque

   • Ioanna Gianopoulos
   • Stella S. Daskalopoulou

   Review 20 January 2024 Pages: 35 - 56

   

3. Targeted ablation of the left middle cervical ganglion prevents ventricular arrhythmias and cardiac injury induced by AMI

   • Meng Zheng
   • Siyu Chen
   • Zhibing Lu

   Original Contribution 28 December 2023 Pages: 57 - 74

   

4. Mast cell stabilizer, an anti-allergic drug, reduces ventricular arrhythmia risk via modulation of neuroimmune interaction

   • Yuhong Wang
   • Zhihao Liu
   • Lilei Yu

   Original Contribution 03 January 2024 Pages: 75 - 91

   

5. Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes

   • Amelie Paasche
   • Felix Wiedmann
   • Constanze Schmidt

   Original Contribution Open access 03 January 2024 Pages: 93 - 112

   

6. Pinacidil ameliorates cardiac microvascular ischemia–reperfusion injury by inhibiting chaperone-mediated autophagy of calreticulin

   • Muyin Liu
   • Su Li
   • Junbo Ge

   Original Contribution Open access 02 January 2024 Pages: 113 - 131

   

7. Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice

   • Qiuyu Sun
   • Cory S. Wagg
   • Gary D. Lopaschuk

   Original Contribution 26 December 2023 Pages: 133 - 150

   

8. Striated preferentially expressed gene deficiency leads to mitochondrial dysfunction in developing cardiomyocytes

   • Gu Li
   • He Huang
   • Mark A. Perrella

   Original Contribution Open access 26 December 2023 Pages: 151 - 168

   

9. Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair

   • Lijuan Pei
   • Zhaohui Ouyang
   • Ke Wei

   Original Contribution 26 December 2023 Pages: 169 - 192